Vimarsana
Biggest News Aggregation in the World

Page 4 - Time Dynamix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Time Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Time Dynamix Today - Breaking & Trending Today

FibroGen/Astellas' EVRENZO (roxadustat) Gaining Traction in the United Kingdom and Germany, according to Spherix Global Insights - Vimarsana News

FibroGen/Astellas' EVRENZO (roxadustat) Gaining Traction in the United Kingdom and Germany, according to Spherix Global Insights

/PRNewswire/ -- After a regulatory debacle in the United States which ended with FibroGen and AstraZeneca receiving a Complete Response Letter in August 2021...

FibroGen/Astellas' EVRENZO (roxadustat) Gaining Traction in the United Kingdom and Germany, according to Spherix Global Insights - Vimarsana News

FibroGen/Astellas' EVRENZO (roxadustat) Gaining Traction in the United Kingdom and Germany, according to Spherix Global Insights

/PRNewswire/ -- After a regulatory debacle in the United States which ended with FibroGen and AstraZeneca receiving a Complete Response Letter in August 2021...

Further Education Needed for the Proper Diagnosis of Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis in the EU5, Spherix Global Insights Reports - Vimarsana News

Further Education Needed for the Proper Diagnosis of Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis in the EU5, Spherix Global Insights Reports

/PRNewswire/ -- Rheumatologists in the EU5 (France, Germany, Italy, Spain, and the United Kingdom) recognize a disconnect in the diagnosis and referral process...

The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports - Vimarsana News

The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports

/PRNewswire/ -- TNF inhibitors continue to be the mainstay for treating psoriatic arthritis (PsA), largely driven by the gold standards, etanercept and...

The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports - Vimarsana News

The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports

/PRNewswire/ -- TNF inhibitors continue to be the mainstay for treating psoriatic arthritis (PsA), largely driven by the gold standards, etanercept and...